Global Oropharyngeal Candidiasis Market is anticipated to Witness Steady Growth owing to Rising Geriatric Population

Market Overview

Oropharyngeal candidiasis, commonly known as thrush, is a fungal infection that grows in the mouth and throat caused by an overgrowth of yeast called Candida albicans. It affects infants, elderly individuals, and those with weakened immune systems. Oral thrush presents as white or yellowish lesions in the mouth and tongue that can be painful. With the growing geriatric population worldwide, the risk of this fungal infection is increasing considerably.

The global oropharyngeal candidiasis market is estimated to be valued at US$ 456 MN in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period of 2024 to 2031.


Key Takeaways


Key players operating in The Global Oropharyngeal Candidiasis Market are Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy Laboratories, Bristol Laboratories, Glenmark Pharmaceuticals Ltd, and GlaxoSmithKline.

The rising prevalence of HIV/AIDS and diabetes presents significant opportunities for players in the market. Aggressive marketing and R&D into novel drug formulations can help capture untapped markets.

Major companies are focusing on expanding their geographic footprints in emerging markets through partnerships with local distributors. Asia Pacific and Latin America are viewed as high growth regions due to developing healthcare infrastructure and large patient pools.

Market Drivers
Increasing geriatric population worldwide: Age is a major risk factor for oral thrush as aging causes lowered immunity. There are over 700 million people aged 65 years and older globally, providing a steady source of patients.

Rising incidence of chronic diseases: Medical conditions such as cancer, HIV/AIDS, diabetes, and autoimmune disorders predispose a person to yeast infections due to immunosuppression. The growing burden of these diseases will drive market growth.

Market Restraints
Invasive treatments required for refractory cases: Severe thrush that does not respond to antifungal medicines may require invasive procedures such as endoscopy for proper diagnosis and treatment, involving higher costs.

Preference for alternative treatment methods: Some patients resort to home remedies like dairy products, herbal medicines, and probiotics to manage mild symptoms before consulting a doctor, limiting revenue opportunities.


Segment Analysis
The global oropharyngeal candidiasis market is dominated by the drug therapy segment. Drug therapy involves antifungal medications to treat oral thrush. The antifungal drugs available for treatment include clotrimazole, miconazole, nystatin, fluconazole, itraconazole, posaconazole and others. Among these, fluconazole leads the drug therapy segment owing to its high efficacy and affordability. It is prescribed as the first line treatment for fungal infections including oral thrush. The other segments include diagnostic procedure and surgical procedure. However, drug therapy accounts for over 70% of the global market since other treatment options are limited to severe cases.

Global Analysis
North America currently dominates the global oropharyngeal candidiasis market and is forecasted to maintain its lead throughout the forecast period. This is attributed to high prevalence of oral thrush in the region and easy availability of advanced treatment options. Additionally, presence of key players has ensured adequate supply of antifungal drugs. Europe holds the second largest share due to growing awareness among patients and physicians regarding standard treatment protocols. Meanwhile, Asia Pacific is anticipated to witness the fastest growth during the forecast period. Rising COVID-19 infections which lowers immunity and increases the risks of opportunistic infections like oral thrush, boosts market growth in the region. High unmet needs in developing countries also present numerous lucrative opportunities for players in Asia Pacific.

 

Get More Insights On Global Oropharyngeal Candidiasis Market

Comments

Post a Comment

Popular posts from this blog

Polyether Ether Ketone Market Estimated To Witness High Growth

 The Polyether Ether Ketone market is estimated to be valued at US$ 729.34 Mn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: Polyether ether ketone (PEEK) is a semi-crystalline thermoplastic that exhibits excellent properties such as chemical resistance, durability, strength and stability even at high temperatures. It is widely used in automotive, aerospace, industrial and medical industries. In automotive industry, PEEK is used to manufacture components of electric and hybrid vehicles due to its high heat resistance and electrical insulation properties. It is also used in manufacturing components of engine, transmission and braking systems. Market Dynamics: The growth of the Polyether ether ketone market is primarily driven by the increasing applications of PEEK in automotive industry. PEEK has high demand from automotive industry due to its abil...
Read more

Osteoporosis Treatment Market Is Estimated To Witness High Growth

Image
The Osteoporosis Treatment market is estimated to be valued at US$ 14.54 Bn or Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Osteoporosis is a progressive systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue leading to bone fragility and increased risk of fractures. The disease affects millions of people worldwide and remains largely underdiagnosed and undertreated. Some common products used in osteoporosis treatment include bisphosphonates, selective estrogen receptor modulators (SERMs), parathyroid hormone (PTH) therapy, and monoclonal antibody drugs. Market Dynamics: The osteoporosis treatment market is driven by the increasing geriatric population worldwide which is highly susceptible to developing osteoporosis. As per the United Nations, the population aged 60 years and above is expected t...
Read more

Eyewear Market Growth Driven by Advancements in Materials and Technologies

Image
  Eyewear Market The eyewear market encompasses a wide range of products intended for vision correction or eyewear style including prescription eyewear, sunglasses, sports eyewear and safety eyewear. Advances in optometry and lens design have enabled the production of progressive and lined multifocal lenses for precise vision correction. Meanwhile, innovations in materials have made lenses lighter, thinner and more durable. Frames are now commonly manufactured using lightweight yet sturdy materials like titanium and nylon. The combination of novel technologies and premium materials allows for high quality vision correction along with stylish design. The global eyewear market is estimated to be valued at US$ 163.01 billion in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period from 2024 to 2031. Key Takeaways Key players operating in the eyewear market include Worksite Lighting LLC, DCD Technologies ME FZCO, Azz Inc., Nemalux Inc., IKIO LED Lighting, Luceco ...
Read more